Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Companies / India

India's IBPL To Launch Oncology Biotech Products

February 2008 | Company News Alert

Demonstrating faith in the Gulf states' appetite for novel drugs, India's Intas Biopharmaceuticals (IBPL) is to register itself in the Gulf Co-operation Council (GCC) region. IBPL is initially planning to launch three products to treat certain cancers and their side effects in the GCC. The products due to be launched are Neukine (rHu G-CSF), Erykine (rHu EPO) and Intalfa (rHu interferon alpha

Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.

[
: *
[
: *

Forgotten your password?

If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.

Free Trial To Pharmaceuticals & Healthcare Insight

TAKE A TRIAL >>
Related Insight Articles
Ranbaxy Enters Yemen

Companies / India Indian generics multinational Ranbaxy Laboratories has entered Yemen's pharmaceutical market through a tie up with Yemen's National Trading Company (Natco). The deal will see Natco market a number of...
May 2008
Glenmark Looks To Chronic Diseases

Companies / India Possibly encouraged by signs that non-communicable chronic diseases such as diabetes and cancer are on the rise in Africa, Glenmark Pharmaceuticals Nigeria, a subsidiary of India's Glenmark Pharmaceuticals...
November 2007
Trade With India Set To Boom

Companies / India South Africa-India bilateral trade is set for strong growth according to the Federation of Indian Chambers of Commerce and Industry (FICCI). Overall trade is expected to reach US$12bn by 2010 - triple...
October 2007
Ranbaxy Expands South African Footprint

Companies / India Indian drugmaker Ranbaxy has expanded its presence in the South African pharmaceuticals market after completing the purchase of local producer Be-Tabs Pharmaceuticals in a deal worth ZAR500mn (US$72.17mn)....
May 2007
Indian Drugmakers Target East Africa

Companies / India Indian drugmaker Plethico Pharmaceuticals is planning to invest KES1.42bn (US$20mn) in a new manufacturing facility in Kenya. The factory is scheduled to begin operations by the end of the year and will...
April 2006
Middle East & Africa InsightMiddle East & Africa Channels Middle East & Africa Countries


All material on this site is protected by international copyright laws and use of this site is subject to our Terms & Conditions.
© 2008 Business Monitor International Ltd
Site powered by WORKSsitebuilder CMS